PTRHD1 | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
conventional dendritic cell	23 studies	33% ± 15%	Explore
classical monocyte	19 studies	27% ± 10%	Explore
plasmacytoid dendritic cell	17 studies	34% ± 13%	Explore
B cell	14 studies	24% ± 7%	Explore
natural killer cell	14 studies	20% ± 5%	Explore
memory B cell	13 studies	20% ± 4%	Explore
ciliated cell	13 studies	30% ± 14%	Explore
epithelial cell	12 studies	36% ± 21%	Explore
CD8-positive, alpha-beta T cell	11 studies	20% ± 4%	Explore
macrophage	11 studies	21% ± 7%	Explore
monocyte	11 studies	24% ± 9%	Explore
regulatory T cell	9 studies	20% ± 4%	Explore
basal cell	8 studies	30% ± 16%	Explore
CD16-positive, CD56-dim natural killer cell, human	8 studies	19% ± 4%	Explore
fibroblast	8 studies	25% ± 7%	Explore
dendritic cell	8 studies	51% ± 22%	Explore
CD16-negative, CD56-bright natural killer cell, human	7 studies	18% ± 2%	Explore
progenitor cell	7 studies	34% ± 12%	Explore
goblet cell	7 studies	27% ± 10%	Explore
non-classical monocyte	6 studies	25% ± 8%	Explore
CD4-positive, alpha-beta T cell	6 studies	19% ± 4%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	6 studies	20% ± 4%	Explore
connective tissue cell	6 studies	22% ± 6%	Explore
endothelial cell	6 studies	28% ± 13%	Explore
pericyte	6 studies	23% ± 5%	Explore
gamma-delta T cell	6 studies	25% ± 14%	Explore
secretory cell	5 studies	24% ± 12%	Explore
myofibroblast cell	5 studies	21% ± 4%	Explore
intestinal crypt stem cell	5 studies	27% ± 6%	Explore
transit amplifying cell	5 studies	19% ± 2%	Explore
type II pneumocyte	5 studies	33% ± 16%	Explore
abnormal cell	5 studies	25% ± 8%	Explore
hematopoietic precursor cell	4 studies	41% ± 8%	Explore
leukocyte	4 studies	22% ± 6%	Explore
naive B cell	4 studies	19% ± 4%	Explore
mononuclear phagocyte	4 studies	29% ± 11%	Explore
effector memory CD8-positive, alpha-beta T cell	4 studies	20% ± 2%	Explore
exhausted T cell	4 studies	25% ± 9%	Explore
T cell	4 studies	17% ± 2%	Explore
enteroendocrine cell	4 studies	29% ± 10%	Explore
mesothelial cell	4 studies	33% ± 18%	Explore
smooth muscle cell	4 studies	18% ± 1%	Explore
erythroblast	4 studies	29% ± 18%	Explore
hematopoietic stem cell	4 studies	26% ± 3%	Explore
club cell	4 studies	23% ± 8%	Explore
effector CD4-positive, alpha-beta T cell	4 studies	22% ± 1%	Explore
effector CD8-positive, alpha-beta T cell	4 studies	21% ± 1%	Explore
CD4-positive, alpha-beta memory T cell	4 studies	21% ± 3%	Explore
CD8-positive, alpha-beta memory T cell	4 studies	25% ± 13%	Explore
deuterosomal cell	3 studies	18% ± 3%	Explore
duct epithelial cell	3 studies	16% ± 1%	Explore
ionocyte	3 studies	18% ± 1%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	3 studies	19% ± 2%	Explore
enterocyte	3 studies	23% ± 2%	Explore
neural crest cell	3 studies	22% ± 4%	Explore
common myeloid progenitor	3 studies	35% ± 13%	Explore
precursor B cell	3 studies	18% ± 1%	Explore
myeloid cell	3 studies	28% ± 11%	Explore
immature B cell	3 studies	22% ± 4%	Explore
type I pneumocyte	3 studies	37% ± 12%	Explore
germinal center B cell	3 studies	27% ± 5%	Explore
intermediate monocyte	3 studies	33% ± 17%	Explore
effector memory CD4-positive, alpha-beta T cell	3 studies	20% ± 3%	Explore
mature NK T cell	3 studies	17% ± 1%	Explore
double negative thymocyte	3 studies	28% ± 15%	Explore
luminal hormone-sensing cell of mammary gland	3 studies	19% ± 4%	Explore
progenitor cell of mammary luminal epithelium	3 studies	29% ± 10%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
peripheral blood	11 studies	22% ± 5%	Explore
lung	8 studies	26% ± 12%	Explore
intestine	8 studies	22% ± 9%	Explore
kidney	3 studies	19% ± 1%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
ovary	100%	368.00	180 / 180	100%	35.81	430 / 430
skin	100%	498.63	1809 / 1809	100%	14.59	472 / 472
thymus	100%	612.64	653 / 653	100%	21.61	605 / 605
uterus	100%	260.23	170 / 170	100%	18.55	459 / 459
brain	100%	569.14	2642 / 2642	100%	17.05	704 / 705
prostate	100%	436.16	245 / 245	100%	35.96	501 / 502
stomach	100%	333.88	358 / 359	100%	17.12	286 / 286
pancreas	100%	280.18	327 / 328	100%	13.62	178 / 178
intestine	100%	382.31	964 / 966	100%	19.40	525 / 527
bladder	100%	361.95	21 / 21	99%	20.56	501 / 504
lung	99%	415.22	575 / 578	100%	17.48	1153 / 1155
breast	100%	416.31	458 / 459	99%	16.24	1109 / 1118
esophagus	99%	367.20	1437 / 1445	99%	13.23	182 / 183
kidney	100%	508.44	89 / 89	98%	11.87	886 / 901
adrenal gland	100%	928.97	258 / 258	98%	13.50	226 / 230
liver	100%	331.36	226 / 226	97%	11.66	394 / 406
eye	0%	0	0 / 0	100%	28.63	80 / 80
lymph node	0%	0	0 / 0	100%	33.47	29 / 29
spleen	100%	440.40	241 / 241	0%	0	0 / 0
tonsil	0%	0	0 / 0	100%	14.17	45 / 45
ureter	0%	0	0 / 0	100%	15.13	1 / 1
muscle	100%	473.37	802 / 803	0%	0	0 / 0
adipose	100%	372.45	1202 / 1204	0%	0	0 / 0
blood vessel	99%	253.88	1319 / 1335	0%	0	0 / 0
heart	98%	393.12	843 / 861	0%	0	0 / 0
peripheral blood	94%	382.90	875 / 929	0%	0	0 / 0
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0

III. Associated gene sets

GO_0004045	Molecular function	aminoacyl-tRNA hydrolase activity
GO_0005515	Molecular function	protein binding

IV. Literature review

[source]

Gene name	PTRHD1
Protein name	Putative peptidyl-tRNA hydrolase PTRHD1 (EC 3.1.1.29) (Peptidyl-tRNA hydrolase domain-containing protein 1)
Synonyms	C2orf79
Description
Accessions	Q6GMV3 ENST00000328379.6

PTRHD1 report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review